Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.

Chicago Board Options ExchangeETF
$28.085
−$4.685 · -14.30%
As of Oct 30, 3:59 PM ET
$26.59
−$1.495 · -5.32%
After hours · As of Oct 30, 7:38 PM ET
Regular session · ET · Market data may be delayed.
TEMT is a leveraged ETF seeking to provide twice the daily performance of Tempus Al Inc., a healthcare AI firm. The fund's objective is strictly for daily returns and is not designed for long-term investment. To meet its leverage goal, the fund primarily engages in swap agreements, options, and direct holdings of Tempus Al (TEM) stock, actively rebalancing each trading day. Its performance is highly tied to TEM's daily price movements and may experience increased volatility compared to traditional funds. Due to its use of derivatives and leverage, the fund should be monitored regularly, as it is intended for short-term trading rather than long-term investing. The fund's concentration reflects TEM's focus on healthcare technology, and its results can vary considerably depending on underlying stock and sector movements.
Fund facts updated Oct 31, 2026.
Day range
Current $28.085
52-week range
Current $28.085
1 month
-28.75%
3 months
+110.85%
Year to date
-18.24%
1 year
-74.45%
Since inception
-68.91%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 3 of 3 reported holdings
Displayed portfolio weight: 100.00%
Holdings data updated Oct 31, 2026.
Dec 23, 2025
Dec 23, 2025
Dec 26, 2025
$11.544
Irregular
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.